Expert Opinion on Drug Safety, Volume 22, Issue 12 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 22, Issue 12 (2023)

See all volumes and issues
Vol 23, 2024 Volume 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Special Report

Report
Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer
Ilana Schlam, Antonio Giordano & Sara M. Tolaney
Pages: 1149-1156
Published online: 18 Dec 2023
AbstractforInterstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 444 Views
  • 0 CrossRef citations
  • 0Altmetric
Report
Nail lichen planus treatment safety
Eden N. Axler & Shari R. Lipner
Pages: 1157-1168
Published online: 18 Dec 2023
AbstractforNail lichen planus treatment safety | Full Text | References | PDF (338 KB) | EPUB
  • 150 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
The safety of oral antifungals for the treatment of onychomycosis
Aditya K. Gupta, Sandor Haas-Neill & Mesbah Talukder
Pages: 1169-1178
Published online: 18 Dec 2023
AbstractforThe safety of oral antifungals for the treatment of onychomycosis | Full Text | References | PDF (363.5 KB) | EPUB
  • 228 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Cardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety review
Francesco Locatelli, Ernesto Paoletti & Lucia Del Vecchio
Pages: 1179-1191
Published online: 18 Dec 2023
AbstractforCardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety review | Full Text | References | PDF (551.2 KB) | EPUB
  • 226 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management
Claudio Laudani, Davide Capodanno & Dominick Joseph Angiolillo
Pages: 1193-1212
Published online: 18 Dec 2023
AbstractforBleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management | Full Text | References | PDF (4.3 MB) | EPUB
  • 110 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia
A. Elif Müderrisoglu, Jean J. M. C. H. de la Rosette & Martin C. Michel
Pages: 1213-1224
Published online: 18 Dec 2023
AbstractforPotential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia | Full Text | References | PDF (332 KB) | EPUB
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
A comparative safety review of targeted therapies for acute myeloid leukemia
Mark Dalgetty, Christian Leurinda & Jorge Cortes
Pages: 1225-1236
Published online: 18 Dec 2023
AbstractforA comparative safety review of targeted therapies for acute myeloid leukemia | Full Text | References | PDF (458.3 KB) | EPUB | Supplemental
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Article
Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis
Siddhartha Dutta, Shubha Singhal, Rima Shah, Jaykaran Charan, Sameer Dhingra & Mainul Haque
Pages: 1237-1251
Published online: 07 Aug 2023
AbstractforDaridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis | Full Text | References | PDF (7.1 MB) | EPUB | Supplemental
  • 248 Views
  • 0 CrossRef citations
  • 0Altmetric
Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials
Anuraag Jena, Chhagan L Birda, Arup Choudhury & Vishal Sharma
Pages: 1253-1263
Published online: 18 Jul 2023
AbstractforSafety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 182 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate
Marko Lucijanic, Nikolina Busic, Josip Stojic, Mislav Barisic-Jaman, Nikola Zagorec, Karla Lazibat, Antica Pasaric, Anamarija Vrkljan Vuk, Ivan Durlen, Josko Mitrovic, Ivica Luksic & Bruno Barsic
Pages: 1265-1270
Published online: 10 Jul 2023
AbstractforProton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rate | Full Text | References | PDF (1.1 MB) | EPUB
  • 166 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Appropriateness of psychopharmacological therapies to psychiatric diagnoses in persons with autism spectrum disorder with or without intellectual disabilities: a cross-sectional analytic study
Rita Di Sarro, Niccolò Varrucciu, Anna Di Santantonio, Francesca Natali, Shaniko Kaleci, Annamaria Bianco, Michela Cappai, F. Lucchi & Marco O. Bertelli
Pages: 1271-1281
Published online: 21 Jan 2023
AbstractforAppropriateness of psychopharmacological therapies to psychiatric diagnoses in persons with autism spectrum disorder with or without intellectual disabilities: a cross-sectional analytic study | Full Text | References | PDF (315.9 KB) | EPUB
  • 631 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study
Romain Barus, François Montastruc, Claire de Canecaude, Haleh Bagheri, Agnès Sommet & Maryse Lapeyre-Mestre
Pages: 1283-1287
Published online: 21 Aug 2023
AbstractforSublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study | Full Text | References | PDF (321 KB) | EPUB | Supplemental
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic
Ravina Barrett
Pages: 1289-1299
Published online: 29 Nov 2022
AbstractforA cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1084 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Impact of preoperative pharmaceutical care consultation on medication errors in surgical patients: a comprehensive analysis
Daniel Gomez Costas, Almudena Ribed Sánchez, Alvaro Gimenez Manzorro, Ignacio Garutti Martinez, Francisco Javier Sanz Fernandez, Beatriz Torroba Sanz, Sergio Herrero Bermejo, Ana María Herranz-Alonso & María Sanjurjo
Pages: 1301-1307
Published online: 18 Dec 2023
AbstractforImpact of preoperative pharmaceutical care consultation on medication errors in surgical patients: a comprehensive analysis | Full Text | References | PDF (266.9 KB) | EPUB | Supplemental
  • 54 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Interstitial lung disease risk of anaplastic lymphoma kinase tyrosine kinase inhibitor treatment of non-small cell lung cancer: a real-world pharmacovigilance study
Min Zhao, Shu Liu, Rui Xie, Jianjun Zhang & Jiang Li
Pages: 1309-1316
Published online: 12 Aug 2023
AbstractforInterstitial lung disease risk of anaplastic lymphoma kinase tyrosine kinase inhibitor treatment of non-small cell lung cancer: a real-world pharmacovigilance study | Full Text | References | PDF (920 KB) | EPUB
  • 314 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data
Li Wang & Bin Zhao
Pages: 1317-1320
Published online: 18 Dec 2023
AbstractforJanus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data | Full Text | References | PDF (221.5 KB) | EPUB
  • 224 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Drug–drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS
Fuhong Qin, Huiling Wang, Meng Li, Shengnan Zhuo & Wei Liu
Pages: 1321-1327
Published online: 24 Jul 2023
AbstractforDrug–drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS | Full Text | References | PDF (1 MB) | EPUB
  • 272 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles